Human Microvascular Endothelial Cells Are Strongly Sensitive to Shiga Toxins

This publication has 27 references indexed in Scilit:

• Comparison of the Effects of Shiga-like Toxin 1 on Cytokine- and Butyrate-Treated Human Umbilical and Saphenous Vein Endothelial Cells
  The Journal of Infectious Diseases, 1996
• Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs.
  The Journal of Experimental Medicine, 1993
• Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome
  Blood, 1992
• Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli
  Nature, 1992
• Monoclonal antibodies against Galα 1 −4Galß 1 −4Glc(P^k, CD77) produced with a synthetic glycoconjugate as immunogen: Reactivity with carbohydrates, with fresh frozen human tissues and hematopoietic tumors
  International Journal of Cancer, 1991
• Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide.
  Proceedings of the National Academy of Sciences, 1990
• Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1
  Journal of Bacteriology, 1988
• Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages fromEscherichia coli933
  FEMS Microbiology Letters, 1987
• The Association Between Idiopathic Hemolytic Uremic Syndrome and Infection by Verotoxin-Producing Escherichia coli
  The Journal of Infectious Diseases, 1985
• Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype
  New England Journal of Medicine, 1983